Lanxess said it has a deal to acquire Emerald Kalama Chemical, a Vancouver, Wash.-based maker of specialty chemicals, for about $1 billion.

Lanxess, based in Germany with North American headquarters in Findlay, announced the deal Sunday.

Emerald Kalama, owned by private equity firm American Securities LLC, has 500 employees and annual sales of $425 million.

About 75% of Emerald Kalama’s revenues are generated by chemicals used in consumer products, including food flavorings and preservatives, cosmetics and animal hygiene. About 25% of sales are chemicals used in industrial applications.

Advertise with us

Nearly half of its sales are in North America.

Lanxess said the deal will expand its presence in disinfectants, including products used to combat the coronavirus and African swine fever.

Last year, as the COVID-19 pandemic spread, Lanxess ramped up production of a disinfectant product used to clean hard surfaces and equipment that was found effective in reducing contamination of a strain of the coronavirus.

The deal to buy Emerald Kalama will help Lanxess achieve “momentum on our growth course” and will boost the company’s efforts to “enlarge our presence in our growth region of North America,” Matthias Zachert, Lanxess’ chairman, said in a statement.

Lanxess, with 14,400 employees worldwide, has about 350 workers in the Pittsburgh region at the Findlay headquarters and plants in Neville Island and Burgettstown, Washington County.

Advertise with us

Emerald Kalama has plants in Kalama, Wash., the Netherlands and Great Britain.

Lanxess expects the deal to close in the second half of the year.

Joyce Gannon: jgannon@post-gazette.com